(Q47994615)

7 February 2018

title

MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder (English)

1 reference

7 February 2018

1 reference

1 reference

Rubén Fernández-Santiago

1

1 reference

7 February 2018

Eduardo Tolosa

6

object named as

Eduardo Tolosa

1 reference

7 February 2018

Alex Iranzo

2

1 reference

7 February 2018

Carles Gaig

3

1 reference

7 February 2018

Mónica Serradell

4

1 reference

7 February 2018

Manel Fernández

5

1 reference

7 February 2018

Joan Santamaría

7

1 reference

7 February 2018

Mario Ezquerra

8

1 reference

7 February 2018

publication date

13 March 2015

1 reference

7 February 2018

published in

Annals of Neurology

1 reference

7 February 2018

volume

77

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

895-901

1 reference

7 February 2018

Diagnosis and the premotor phase of Parkinson disease

cites work

1 reference

Can we define "pre-motor" Parkinson's disease?

21 January 2018

1 reference

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study

21 January 2018

1 reference

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

21 January 2018

1 reference

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

21 January 2018

1 reference

Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients

21 January 2018

1 reference

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

21 January 2018

1 reference

Alterations of the microRNA network cause neurodegenerative disease.

21 January 2018

1 reference

Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504.

21 January 2018

1 reference

A microRNA-based gene dysregulation pathway in Huntington's disease

21 January 2018

1 reference

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

21 January 2018

1 reference

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

21 January 2018

1 reference

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

MicroRNAs and neurodegeneration: role and impact

21 January 2018

1 reference

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

Role of Personalized Medicine in the Identification and Characterization of Parkinson's Disease in Asymptomatic Subjects

21 January 2018

1 reference

Identification of serum microRNA signatures for diagnosis of mild traumatic brain injury in a closed head injury model.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24384

1 reference

7 February 2018

1 reference

7 February 2018